Similar Items: Over 600 million people aged 18–65 will have headache tomorrow: global 1-day prevalence and recall bias from a meta-analysis of individual participant data (N = 38,512) from the general populations of 15 countries
- CGRP-provoked headache is associated with a neuroimmune signature in idiopathic intracranial hypertension
- Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Obstetric Population: A Narrative Review
- White matter microstructural alterations in episodic cluster headache outside attacks: a tract-based spatial statistics study
- Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial
- Anesthetic and Analgesic Management of Pediatric Patients for Staged Repeat Same-Day Surgery
- Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis